These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26452418)

  • 1. Does larger tumor volume explain the higher prostate specific antigen levels in black men with prostate cancer--Results from the SEARCH database.
    Klaassen Z; Howard L; Terris MK; Aronson WJ; Cooperberg MR; Amling CL; Kane CJ; Freedland SJ
    Cancer Epidemiol; 2015 Dec; 39(6):1066-70. PubMed ID: 26452418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
    Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
    JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database.
    Hamilton RJ; Aronson WJ; Presti JC; Terris MK; Kane CJ; Amling CL; Freedland SJ
    Cancer; 2007 Nov; 110(10):2202-9. PubMed ID: 17876838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients.
    Moul JW; Connelly RR; Mooneyhan RM; Zhang W; Sesterhenn IA; Mostofi FK; McLeod DG
    J Urol; 1999 Aug; 162(2):394-7. PubMed ID: 10411045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens.
    Pettaway CA; Troncoso P; Ramirez EI; Johnston DA; Steelhammer L; Babaian RJ
    J Urol; 1998 Aug; 160(2):437-42. PubMed ID: 9679893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. African-American men with prostate cancer have larger tumor volume than Caucasian men despite no difference in serum prostate specific antigen.
    Fuletra JG; Kamenko A; Ramsey F; Eun DD; Reese AC
    Can J Urol; 2018 Feb; 25(1):9193-9198. PubMed ID: 29524974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race and risk of metastases and survival after radical prostatectomy: Results from the SEARCH database.
    Freedland SJ; Vidal AC; Howard LE; Terris MK; Cooperberg MR; Amling CL; Kane CJ; Aronson WJ;
    Cancer; 2017 Nov; 123(21):4199-4206. PubMed ID: 28654204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.
    Bissonette EA; Fulmer BR; Petroni GR; Moul JW; Theodorescu D
    J Urol; 2001 Oct; 166(4):1328-31; discussion 1331-2. PubMed ID: 11547067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease recurrence in black and white men undergoing radical prostatectomy for clinical stage T1-T2 prostate cancer.
    Eastham JA; Kattan MW
    J Urol; 2000 Jan; 163(1):143-5. PubMed ID: 10604332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
    Eastham JA; Carver B; Katz J; Kattan MW
    Prostate; 2002 Mar; 50(4):236-40. PubMed ID: 11870801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies.
    Fowler JE; Bigler SA; Kilambi NK; Land SA
    Urology; 1999 Jun; 53(6):1175-8. PubMed ID: 10367848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Hispanic race an independent risk factor for pathological stage in patients undergoing radical prostatectomy?
    Lam JS; Desai M; Mansukhani MM; Benson MC; Goluboff ET
    J Urol; 2003 Dec; 170(6 Pt 1):2288-91. PubMed ID: 14634398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men.
    Sanchez-Ortiz RF; Troncoso P; Babaian RJ; Lloreta J; Johnston DA; Pettaway CA
    Cancer; 2006 Jul; 107(1):75-82. PubMed ID: 16736511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Black and White men younger than 50 years of age demonstrate similar outcomes after radical prostatectomy.
    Moses KA; Chen LY; Sjoberg DD; Bernstein M; Touijer KA
    BMC Urol; 2014 Dec; 14():98. PubMed ID: 25495177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer.
    Henderson RJ; Eastham JA; Culkin DJ; Kattan MW; Whatley T; Mata J; Venable D; Sartor O
    J Natl Cancer Inst; 1997 Jan; 89(2):134-8. PubMed ID: 8998182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory infiltrate (prostatitis) in whole mounted radical prostatectomy specimens from black and white patients is not an etiology for racial difference in prostate specific antigen.
    Zhang W; Sesterhenn IA; Connelly RR; Mostofi FK; Moul JW
    J Urol; 2000 Jan; 163(1):131-6. PubMed ID: 10604330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do racial differences in prostate size explain higher serum prostate-specific antigen concentrations among black men?
    Mavropoulos JC; Partin AW; Amling CL; Terris MK; Kane CJ; Aronson WJ; Presti JC; Mangold LA; Freedland SJ
    Urology; 2007 Jun; 69(6):1138-42. PubMed ID: 17572202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.
    Fowler JE; Bigler SA; Farabaugh PB
    Cancer; 2002 Mar; 94(6):1661-7. PubMed ID: 11920526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial differences in serum prostate-specific antigen (PSA) doubling time, histopathological variables and long-term PSA recurrence between African-American and white American men undergoing radical prostatectomy for clinically localized prostate cancer.
    Tewari A; Horninger W; Badani KK; Hasan M; Coon S; Crawford ED; Gamito EJ; Wei J; Taub D; Montie J; Porter C; Divine GW; Bartsch G; Menon M
    BJU Int; 2005 Jul; 96(1):29-33. PubMed ID: 15963115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
    Lediju O; Ikuemonisan J; Salami SS; Adejoro O
    J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.